Medtronic Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One decreased by 0.1% to $1.55B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 0.2%, from $1.55B to $1.55B. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher values indicate greater near-term liquidity from the investment portfolio, reducing reliance on external financing.
This represents the portion of the available-for-sale debt securities portfolio that is scheduled to mature within the f...
Consistent with standard treasury management practices for large-cap firms with significant cash reserves.
other_available_for_sale_securities_debt_maturities_with_de2040| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.17B | $2.30B | $2.21B | $1.38B | $1.42B | $1.38B | $1.34B | $1.36B | $1.48B | $1.45B | $1.48B | $1.55B | $1.42B | $1.55B | $1.55B |
| QoQ Change | — | +5.9% | -4.0% | -37.6% | +3.0% | -2.7% | -3.0% | +1.6% | +9.0% | -2.2% | +1.9% | +4.9% | -8.3% | +8.9% | -0.1% |
| YoY Change | — | — | — | -36.5% | -38.3% | -37.5% | -2.8% | -4.2% | +7.4% | +8.3% | +8.7% | +4.6% | -1.9% | +4.9% | -0.2% |